Home > Newsletters > FDAnews Drug Daily Bulletin > Retailer Suit Alleges Pfizer, Ranbaxy Flimflammed to Stall Generic Lipitor
FDAnews Drug Daily Bulletin
July 19, 2012 | Vol. 9 No. 141
Retailer Suit Alleges Pfizer, Ranbaxy Flimflammed to Stall Generic Lipitor
Five retailers have sued Pfizer and Ranbaxy, alleging the drugmakers conspired to delay market entry of generic Lipitor in the U.S. Their ploy: “sham” compacts that forced the retailers to pay hundreds of millions of dollars more for atorvastatin than they otherwise would have, according to the lawsuit. In their antitrust suit filed July 5 in the U.S. District Court for the District of New Jersey, Walgreen, Kroger, Safeway, SuperValu and HEB Grocery accuse the pharma giants of entering into an “unlawful contract, combination and conspiracy” that successfully subdued generic competition for 20 months after the blockbuster cholesterol drug’s original patent had expired.
Washington Drug Letter
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.